Fulminant Hepatitis A in Intravenous Drug Users with Chronic Liver Disease

Abstract

Brief reports of new clinical or laboratory observa-tions, cases of unusual importance, and new develop-ments in medical care will be considered for publica-tion in this section. Manuscripts must be typed double-spaced. Text length must not exceed 750 words; not more than ten references and one figure or table can be used. See "Information for Readers and Authors " for form of references. Manuscripts should include an abstract of not over 150 words. Reports will be reviewed by consultants when, in the opinion of the editors, such review is needed. The Editor re-serves the right to shorten reports and to make chang-es in style.